Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Dallas, Texas 75390


The primary purpose of this study is to determine the efficacy and safety of cobiprostone (at two dose levels) as compared to placebo for lowering portal hypertension.


Inclusion Criteria: - Patient is >= 18 years of age. - Patient has clinical and/or pathological diagnosis of intra-hepatic portal hypertension. - Patient has clinical diagnosis of cirrhosis. - Patient has undergone variceal banding. Exclusion Criteria: - Patient has a Child-Pugh score >12. - Patient has portal hypertension resulting from hepatic vein obstruction, portal vein occlusion, schistosomiasis, portal vein thrombosis, splenic vein thrombosis, or Budd-Chiari syndrome. - Variceal banding procedure was performed within 1 month of the screening visit. - Patient has active or recurrent variceal bleeding, or has had variceal bleeding within the 12 weeks prior to screening. - Patient is unwilling to discontinue use of vasoactive drugs from the screening visit through the end of the study. - Patient has hepatocellular carcinoma that is being medically treated or is advanced. - Patient has impaired renal function (i.e., serum creatinine concentration >1.8 mg/dl) - Patient has a history of liver transplant, or is expected to receive a liver transplant during the study period. - Patient has undergone a gastrointestinal or abdominal surgical procedure within 90 days prior to the Screening Visit, or has had a bowel resection at any time.



Primary Contact:

Principal Investigator
Don Rockey, MD
University of Texas Southwestern Medical Center

Backup Contact:


Location Contact:

Dallas, Texas 75390
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.